Never Miss Important Company Updates Again
Get AI-powered summaries of SEC filings delivered to your inbox
Follow your favorite stocks and get email alerts when they release important updates. Completely free.
Prothena Corporation plc is a biotechnology company specializing in protein dysregulation to develop therapies for neurodegenerative and rare amyloid diseases. Its pipeline includes antibody, vaccine, and small molecule programs targeting conditions like Alzheimer’s, Parkinson’s, and amyloidosis. The company leverages deep scientific expertise, strategic collaborations, and innovative targeting of pathogenic proteins to address unmet medical needs in serious, life-threatening diseases.
This description was generated via AI from an annual report. Updated about 1 year ago.